Sun Pharma brimming with health

Sun Pharma which had hit  a new high on 7^th  Nov at Rs.894.90 has today hit another new high at Rs.932.

The stock has hit a new high, enthused with the performance of its subsidiary Taro Pharma. For quarter ended 30^th Sept 2014, it posted a 48% (YoY) jump in its net profit at $143 million with margins going up from 58.6% to 63.9%.

The market is now expecting Sun Pharma to also post very good consolidated numbers for Q2Fy15 based on its subsidiaries performance. The results are scheduled for 13^th Nov.